Compounds for pdt
AssigneeBioscience Technology Investment Holdings Limited
InventorsPaul Bradley, Mehar Manku
Life of this patent
Estimating the term…
Abstract
A tetrakis(hydroxyphenyl)chlorin, bacteriochlorin or isobacteriochlorin, derivatised at one or more of the hydroxy groups by addition reaction with a diisocyanate, diisothiocyanate or isocyanate-isothiocyanate at one isocyanate or isothiocyanate group thereof, the other isocyanate or isothiocyanate group being itself derivatised by addition reaction with the hydroxy group of an w-alkylated or acylated poly(alkylene oxide) or to a hydroxy group of a link residue itself carrying a residue of such poly(alkylene oxide).
Claims5
A tetrakis(hydroxyphenyl)chlorin, bacteriochlorin or isobacteriochlorin, derivatised at one or more of the hydroxy groups by addition reaction with a diisocyanate, diisothiocyanate or isocyanate-isothiocyanate at one isocyanate or isothiocyanate group thereof, the other isocyanate or isothiocyanate group being itself derivatised by addition reaction with the hydroxy group of an ω-alkylated or acylated poly(alkylene oxide) or to a hydroxy group of a link residue itself carrying a residue of such poly(alkylene oxide).
A tetrakis(hydroxyphenyl) chlorin, bacteriochlorin or isobacteriochlorin of formula (12), (13) or (14) or imino tautomer thereof,
- wherein n=1 to 3 and each substituent R the same or different may be a hydroxyl (OH) group itself free or substituted with a C1 to C12 alkyl or acyl group or otherwise derivatised, but in at least one and desirably more than one instance is of formula (15);
- where:
- (i) each X, the same or different is O, S;
- (ii) Y is O (carbamate or thiocarbamate link);
- (iii) A is a hydrocarbon group containing 2 to 40 carbon atoms, preferably 4 to 20 carbon atoms and very preferably 6 carbon atoms (this group may be branched or unbranched, cyclic or acyclic, saturated or unsaturated, aliphatic or aromatic);
- (iv) B is an optional group ((CH2)p—O)q where p=1 to 4;
- q=0,1
- (v) D is a poly(alkylene oxide), preferably polyethylene glycol, with an average molecular weight of at least 200 and not more than 40,000, preferably 750 to 20,000 and very preferably 2,000 to 5,000 Da;
- (vi) E is an alkyl or acyl group containing 1 to 12 carbon atoms, preferably a methyl group;
- and any pharmaceutically acceptable derivative of such chlorin, bacteriochlorin or isobacteriochlorin as a salt with a mineral or other acid or a metal complex or a hydrate or other solvate.
The compounds 7,8-Dihydro-5,10,15,20-tetrakis(3-hydroxyphenyl)porphyrin derivatised with ω-methoxy polyethylene glycol (average MW=2000) via biscarbamate linkages derived from hexane-1,6-diisocyanate;
- 7,8,17,18-Tetrahydro-5,10,15,20-tetrakis(3-hydroxyphenyl)porphyrin derivatised with ω-methoxy poly(ethylene glycol) (average MW=2000) via bis carbamate linkages derived from hexane-1,6-&isocyanate;
- 7,8-Dihydro-5,10,15,20-tetrakis(3-hydroxyphenyl)porphyrin derivatised with ω-methoxy poly(ethylene glycol) (average MW=5000) via bis carbamate linkages derived from hexane-1,6diisocyanate;
- 7,8,17,1 8-Tetrahydro-5,10,15,20-tetrakis(3-hydroxyphenyl) porphyrin derivatised with ω-methoxy poly(ethylene glycol) (average MW=5000) via bis carbamate linkages derived from hexane-1,6 isocyanate
Dependencies are inferred from the claim text.